 prognost valu serum microglobulin low-grad lymphoma object serum microglobulin prognost indic untreat low-grad lymphoma design cohort studi patient uniformli low-grad lymphoma median month patient drawn week therapi cohort untreat patient clinic trial set tertiari referr cancer center patient eighti stage IV patient mean age year intervent treatment ann arbor stage patient stage IV chop-bleomycin interferon therapi stage iii chop-bleomycin radiotherapi stage II cop-bleomycin radiotherapi measur outcom complet remiss rate time treatment failur univari multivari analys result complet remiss rate patient level mg/l level mg/l multivari analysi continu variabl signific factor complet respons adjust odd ratio CI ann arbor stage margin signific odd ratio CI time treatment failur variabl multivari model month patient level mg/l remiss patient level mg/l conclus serum level good predictor complet respons time treatment failur number patient role independ variabl stage age